BRAEMS PHARMA CONSULTING
ActiveSummary
BRAEMS PHARMA CONSULTING has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €242,679 and a net result of €50,137. Equity has been growing by about 33% per year since 2019. Its solvency ranks better than 84% of 39,242 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 06-02-2019 Normal situation
- Activity
- Business and other management consultancy NACE 70200
- Establishment unit
- 2.285.461.144 1495 Villers-la-Ville, since 06-02-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 23-12-2025
Board and ownership
- BRAEMS ThérèseDirector · since 06-02-2019
- WAGNEUR MichelDirector · since 06-02-2019
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €72,157
- ▼ 8.9%
- Turnover
- ≈ €150,000
- estimated
- Profit
- €50,137
- ▼ 8.9%
- Equity
- €242,679
- ▲ 26.0%
- Total assets
- €284,276
- ▲ 15.5%
- 2025 accounts filed 54 days after the deadline
Score breakdownraises riskLast filed accounts filed 54 days late; 1 of the last 3 accounts latelowers riskLiquidity: current ratio 6.77, cash €260,151Sector: Activities of head offices; management consultancy activities (NACE 70)Equity €242,679 (85.4% of total assets)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 70, micro). It does better than 86% of them on solvency, 91% on liquidity, 60% on profitability and 70% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 15 days after the deadline. In the sector (NACE 70), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Amendment of the articles · Legal-form change
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as BRAEMS PHARMA CONSULTING: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €258,000 and €314,000, founded between 2018 and 2020.
| Company | Total assets | Gross margin |
|---|---|---|
| BRAEMS PHARMA CONSULTING Villers-la-Ville | €284,276 | €72,157 |
| SELOFRA Ottignies-Louvain-la-Neuve | €303,469 | €68,790 |
| EZPZ Lasne | €258,507 | €75,530 |
| DM-Co Waterloo | €298,004 | €81,385 |
| NextStep Consulting Rixensart | €258,208 | €72,828 |
| PinkTrees Walhain | €313,682 | €66,902 |
| Isabelle SWOLFS Ottignies-Louvain-la-Neuve | €280,661 | €70,252 |
Key facts about BRAEMS PHARMA CONSULTING
- What is the company number of BRAEMS PHARMA CONSULTING?
- The company number of BRAEMS PHARMA CONSULTING is 0719.866.791. The VAT number is the same number with BE in front: BE 0719.866.791.
- Where is BRAEMS PHARMA CONSULTING based?
- The registered office is at Rue du Try 16, 1495 Villers-la-Ville.Company details
- What does BRAEMS PHARMA CONSULTING do?
- According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
- What is the legal form of BRAEMS PHARMA CONSULTING?
- The legal form of BRAEMS PHARMA CONSULTING is Limited partnership (Comm.V).
- When was BRAEMS PHARMA CONSULTING founded?
- BRAEMS PHARMA CONSULTING was founded on 06-02-2019.
- Is BRAEMS PHARMA CONSULTING still active?
- Yes, BRAEMS PHARMA CONSULTING is an active enterprise in the KBO register.
- What is the turnover of BRAEMS PHARMA CONSULTING?
- The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €72,157 and 119 comparable companies (NACE 70200). It probably lies between €110,000 and €190,000.Financials
- Is BRAEMS PHARMA CONSULTING profitable?
- In financial year 2025, BRAEMS PHARMA CONSULTING made a profit of €50,137.
- Where can I find the annual accounts of BRAEMS PHARMA CONSULTING?
- BRAEMS PHARMA CONSULTING filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BRAEMS PHARMA CONSULTING due?
- BRAEMS PHARMA CONSULTING must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.